File picture of a signboard of Anglo-Swedish pharmaceutical company AstraZeneca pictured in Macclesfield in northwest England, on November 20, 2008. AstraZeneca said on January 29, 2009, it will axe 7,000 more jobs by 2013, extending a cost-cutting programme that has already shed about 8,000 positions since 2007. AstraZeneca is the latest drugs giant to unveil job losses after similar announcements last year by British rival GlaxoSmithKline, German pharmaceutical and chemical group Merck and US group Schering-Plough. Getty Images logo Getty Images 12 months ago

File picture of a signboard of Anglo-Swedish pharmaceutical company AstraZeneca pictured in Macclesfield in northwest England, on November 20, 2008. AstraZeneca said on January 29, 2009, it will axe 7,000 more jobs by 2013, extending a cost-cutting programme that has already shed about 8,000 positions since 2007. AstraZeneca is the latest drugs giant to unveil job losses after similar announcements last year by British rival GlaxoSmithKline, German pharmaceutical and chemical group Merck and US group Schering-Plough.